Alkoxy-5-nitrosopyrimidines: Useful building block for the generation of biologically active compounds

European Journal of Organic Chemistry

Volumn , Issue 20, 2010, Pages 3823-3830

  Marchal, Antonio ^a   Nogueras, Manuel ^a   Sánchez, Adolfo ^a   Low, John N ^b   Naesens, Lieve ^c   De Clercq, Erik ^c   Melguizo, Manuel ^a  

^a UNIVERSITY OF JAÉN   (Spain)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Animation; Antiviral agents; Nitrogen heterocycles; Nitrosation; Nucleophilic substitution

Indexed keywords

EID: 77954306756     PISSN: 1434193X     EISSN: 10990690     Source Type: Journal    
DOI: 10.1002/ejoc.201000195     Document Type: Article

References (69)

1. a) D. T. Hurst, in: An Introduction to the Chemistry and Biochemistry of Pyrimidines, Purines and Pteridines, Wiley, Chichester, 1980;
2. b) D. J. Brown, in: Comprehensive Heterocyclic Chemistry (Eds.: A. R. Katrizky, C. W. Rees), Pergamon Press, Oxford, 1984, vol. 3, chapter 2.13;
3. c) D. J. Brown, in: The Pyrimidines, Interscience Publishers, New York, 1994;
4. d) M. Melguizo, M. Nogueras, A. Sánchez, J. Org. Chem. 1992, 57, 559565.
5. a) H. Vorbrüggen, Adv. Heterocyci Chem. 1990, 49, 117-192, and references cited, therein;
6. b) A. Turck, N. Pié, F. Mongin, G. Quéguiner, Tetrahedron 2001, 57, 4489-4505;
7. c) J. M. Schomaker, T. J. Delia, J. Heterocycl Chem. 2001, 66, 7125-7128, and references cited therein.
8. a) Z. H. Peng, M. Journet, G. Humphrey, Org. Lett. 2006, 8, 395-398;
9. b) C. Wéber, A. Demeter, I. Greiner, Tetrahedron 2006, 62, 2304-2312, and references cited, therein;
10. c) E. A. Arvantis, N. Chadha, R. S. Pottorf, M. R. Player, J. Comb Chem. 2004, 6, 414-419;
11. d) D. Montebugnoli, P. Bravo, E. Brenna, C. Mioskowski, W. Panzeri, F. Viani, A. Volonterio, A. Wagner, M. Zanda, Tetrahedron 2003, 59, 7147-7156;
12. e) C. Zueca, P. Bravo, A. Volonterio, M. Zanda, A. Wagner, C. Mioskowski Tetrahedron Lett. 2001, 42, 1033-1035;
13. f) C. Barillari, D. Barlocco, L. F. Raveglia, Eur. J. Org. Chem. 2001, 4737-4741.
14. For early examples, see: a) S. Gabriel, Ber. Dtsch. Chem. Ges. 1901, 34, 3362-3366;
15. b) E. Büttner, Ber. Dtsch. Chem. Ges. 1903, 36, 2227-2235;
16. c) W. Winkelmann, J. Prakt. Chem. 1927, 115, 292-314;
17. d) W. R. Boon, J. Chem. Soc. 1952, 1532-1533.
18. For recent examples, see: a) L. Joubran, W. R. Jackson, E. M. Campi, A. J. Robinson, B. A. Wells, P. D. Godfrey, J. K. Callaway, B. Jarrot, Aust. J. Chem. 2003, 56, 597-605;
19. b) D. R. Luthin, Y. Hong, E. Tompkins, K. L. Anderes, G. Paderes, E. A. Kraynov, M. A. Castro, K. D. Nared-Hood, R. Castillo, M. Gregory, H. Vazir, J. M. May, M.. B. Anderson, Bioorg. Med. Chem. Lett. 2002, 12, 3635-3645;
20. c) J. M. Schomaker, T. J. Delia, J. Heterocycl Chem. 2000, 37, 1457-1462;
21. d) L. M. Popova, E. P. Studentsov, Russ. J. Org. Chem. 1996, 32, 749-755.
22. Better regioselectivity is described in: a) R. L. Beingessner, B,L. Deng, P. E. Fanwick, H. Fenniri, J. Org. Chem 2008, 73, 931-939;
23. b) Z. H. Peng, M. Journet, G. Humphrey, Org. Lett. 2006, 8, 395-398;
24. c) D. Montebugnoli, P. Bravo, E. Corradi, G. Dettori, C. Mioskowski, A. Volonterio, A. Wagner, M.. Zanda, Tetrahedron 2002, 58, 2147-2153;
25. d) M, Zanda, P. Talaga, A. Wagner, C. Mioskowski, Tetrahedron Lett. 2000, 41, 17571761.
26. a) C. Li, A. Rosenau, Tetrahedron Lett. 2009, 50, 5888-5893;
27. b) C. W. van der Westhuyzen, A. L. Rousseau, C. J. Parkinson, Tetrahedron 2007, 63, 5394-5405;
28. c) S. Ding, N. S. Gray, X. Wu, Q. Ding, P. G. Schultz, J. Am. Chem. Soc. 2002, 124, 15941596.
29. a) P. J. Manley, A. E. Balitza, M. T. Bilodeau, C. E. Coll, G. D. Hartman, R. C. McFaIl, K. W. Rickert, L. D. Rodman, K. A. Thomas, Bioorg. Med. Chem. Lett. 2003, 13, 1673-1677;
30. b) F. Guillier, P. Roussel, H. Moser, P. Kane, M.. Bradley, Chem. Eur. J. 1999, 5, 3450-3458.
31. a) S. Narayan, T. Seelhammer, R. E. Gawley, Tetrahedron Lett. 2004, 45, 757-759;
32. b) G. Luo, L. Chen, S. Poindexter, 'Tetrahedron Lett. 2002, 43, 5739-5742.
33. M. Melguizo, A. Marchal, M. Nogueras, A. Sánchez, J. N. Low, J. Heterocycl Chem. 2002, 39, 97-103.
34. In this sense, the activating effect of the nitro group on the aminolysis has been most studied and, therefore, most synthetically employed. Nevertheless, from a synthetic point of view, it must be taken into account that the nitro group is remarkably resistant to reduction compared to the nitroso group. For recent illustrative examples, see: a) O. B. Riabova, V. A. Makarov, V. G. Granik, C. Párkányi, J. Heterocycl Chem. 2008, 45, 621643;
35. b) L. G. J. Hammarström, M. E. Meyer, D. B. Smith, F. X. Talamás, Tetrahedron Lett. 2003, 44, 8361-8363;
36. c) N. Baindur, N. Chadha, M. R. Player, J. Comb. Chem. 2003, 5, 653-659;
37. d) R. Di Lucrezia, I. H. Gilbert, D. D. Floyd, J. Comb. Chem. 2000, 2, 249-253.
38. As a rule, amines attack nitrosobenzenes at the N-atom of the nitroso group, however, in these reactions, the nitroso group remained intact, see: J. H. Boyer, in: The Chemistry of the Nitro and Nitroso Groups (Ed.: H. Feuer), Wiley-Interscience, New York, 1970, vol. 12, pp. 278-280.
39. a) F. Marchetti, K. L. Sayle, J. Bentley, W. Clegg, N. J. Curtin, J. A. Endicott, B. T. Golding, R. J. Griffin, K. Haggerty, R. W. Harrington, V. Mesguiche, D. R. Newell, M. E. Noble, R. J. Parsons, D. J. Pratt, L. Z. Wang, I. R. Hardcastle, Org. Biomol Chem. 2007, 10, 1577-1585;
40. b) V. Mesguiche, R. J.'Parsons, C. E. Arris, J. Bentley, F. T. Boyle, N. J. Curtin, T. G. Davies, J. A. Endicott, A. E. Gibson, B. T. Golding, R. J. Griffin, P. Jewsbury, L. N. Johnson, D. R. Newell, M. E. M. Noble, L. Z. Wang, I. R. Hardcastle, Bioorg. Med. Chem. Lett. 2003, 13, 217-222;
41. c) K. L. Sayle, J. Bentley, F. T. Boyle, A. H. Calvert, Y. Cheng, N.J. Curtin, J. A. Endicott, B. T. Golding, I. R. Hardcastle, P. Jewsbury, V. Mesguiche, D. R. Newell, M. E. M. Noble, R. J. Parsons, D. J. Pratt, L. Z. Wang, R. J. Griffin, Bioorg. Med. Chem. Lett. 2003, 13, 3079-3082;
42. d) C. E. Arris, F. T. Boyle, A. H. Calvert, N. J. Curtin, J. A. Endicott, E. F. Garman, A. E. Gibson, B. T. Golding, S. Grant, R. J. Griffin, L. N. Johnson, A. M. Lawrie, D. R. Newell, M. E. M. Noble, E. A. Sausville, R. Schultz, W. Yu, J. Med. Chem. 2000, 43, 27972804.
43. a) I. Terashima, K. Kohda, J. Med. Chem. 1998, 41, 503-508;
44. b) M.-Y. Chae, K. Swenn, S. Kanugula, M. Dolan, A. E. Pegg, R. C. Moschei, J. Med. Chem. 1995, 38, 359-365.
45. A. Marchai, M. Melguizo, M. Nogueras, A. Sánchez, J. N. Low, Synlett 2002, 255-258.
46. G. Ritzman, K. lenaga, L. Kiriasis, W. Pfleiderer, Chem. Ber. 1.980, 113, 1535-1548.
47. R. B. Moodie, B. O'Sullivan, J. Chem. Soc. Perkin Trans. 2 1995, 205-208.
48. J. N. Low, D. Cannon, A. Quesada, A. Marchai, M. Melguizo, M. Nogueras, A. Sánchez, C. Glidewell, Acta Crystallogr., Sect. C 2001, 57, 604-607.
49. 6]- DMSO). A. similar observation on benzene nitroso derivatives can be found in: D. L. Lipilin, A. M. Churakov, S. L. Ioffe, Y. A. Strelenko, V. A. Tartakovsky, Eur. J. Org. Chem. 1999, 29-35.
50. J. N. Low, A. Marchai, M. Nogueras, M. Melguizo, A. Sánchez, Acta Crystallogr., Sect. C 2001, 57, 178-179.
51. a) F.-L. Zhang, W.B. Schweizer, M. Xu, A. Vasella, Helv. Chim. Acta 2007, 90, 521-534;
52. b) I. Susvilo, A. Brukstus, S. Tumkevicius, Tetrahedron Lett. 2005, 46, 1841-1844;
53. c) A. Quesada, A. Marchai, M. Melguizo, J. N. Low, C. Glidewell, Acta Crystallogr., Sect. B 2004, 60, 76-89;
54. d) M. Melguizo, A. Quesada, J. N. Low, C. Glidewell, Acta Crystallogr., Sect. B 2003, 59, 263-276;
55. e) A. Quesada, A. Marchai, M. Melguizo, M. Nogueras, A. Sánchez, J. N. Low, D. Cannon, D. M. M. Farrell, C. Glidewell, Acta Crystallogr., Sect. B 2002, 58, 300-315.
56. March's Advanced Organic Chemistry: Reactions, Mechanisms, and Structure, 6th ed. (Eds.: M. B. Smith, J. March), WileyInterscience, 2007.
57. R. E. Akpojivi, T. A. Emokpae, E. Hirst, J. Chem. Soc. Perkin Trans. 2 1994, 443-449.
58. Interesting theoretical investigations focused, on restricted. Cnitroso rotation can be found in: a) G. Urbelis, I. Susvilo, S. Tumkevicius, J. Mol. Model. 2007, 13, 219-224;
59. b) M. H. Holschbach, D. Sanz, R. M. Claramunt, L. Infantes, S. Motherwell, P. R. Raithby, M. L. Jimeno, D. Herrero, I. Alkorta, N. Jagerovic, J. Elguero, J. Org. Chem. 2003, 68, 88318837;
60. c) D. A. Fletcher, B. G. Gowenlock, K. G. Orrell, J. Chem. Soc. Perkin Trans. 2 1998, 797-803;
61. d) J. D. Bolton, M. R. Peterson, R. A. McClelland, Can. J. Chem. 1988, 66, 3044-3049.
62. C. N. R. Rao, K. B. Bhaskar, in: The Chemistry of the Nitro and Nitroso Groups (Ed.: H. Feuer), Wiley, New York, 1969, part 1, chapter 3, p. 137.
63. For recent examples of the biological potential of dihydropteridinones, see: a) X. Li, E. Shocron, A. Song, N. Patel, C. L. Sun, Bioorg. Med. Chem. Lett. 2009, 19, 2860-2864;
64. b) D. Rudolph, M. Steegmaier, M. Hoffmann, M. Grauert, A. Baum, J. Quant, C. Haslinger, P. Garin-Chesa, G. R. Adolf, Clin. Cancer Res. 2009, 15, 3094-3102.
65. M. Melguizo, M. Nogueras, A. Sánchez, Synthesis 1992, 491494.
66. W. R. Boon, T. Leigh, J. Chem. Soc. 1951, 1497-1501.
67. J. Cobo, M. Nogueras, J. N. Low, R. Rodriguez, Tetrahedron Lett. 2008, 49, 7271-7273.
68. E. De Clercq, In vivo and ex vivo Test Systems to Rationalize Drug Design and Delivery (Eds.: D. Cromelin, P. Couvreur, D. Duchene), Editions de Santé, Paris, 1994.
69. C. Glidewell, J.N. Low, A. Marchai, M. Melguizo, A. Quesada, Acta. Crystallogr., Sect. C 2002, 58, 655-667.